Sort
48,018 grants matching “immunotherapy”
RNA-based Immunotherapy Targeting Antigens Unique to Brain Tumor Stem Cells
$523,631John H Sampson · Duke University · R01 · FY2010 · CA
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy
$523,587Weiqiang Chen · New York University · R01 · FY2021 · CA
4DN Interrogation of T Cell Exhaustion in Cancer
$523,564Ansuman Satpathy · Stanford University · U01 · FY2021 · CA
4DN Interrogation of T Cell Exhaustion in Cancer
$523,564Ansuman Satpathy · Stanford University · U01 · FY2020 · CA
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
$523,564James R. Heath · Institute For Systems Biology · R01 · FY2025 · CA
4DN Interrogation of T Cell Exhaustion in Cancer
$523,562Ansuman Satpathy · Stanford University · U01 · FY2023 · CA
4DN Interrogation of T Cell Exhaustion in Cancer
$523,562Ansuman Satpathy · Stanford University · U01 · FY2022 · CA
TCR signaling and cell cycle regulation in tumor-specific CD8 T cell dysfunction
$523,449Mary Philip · Vanderbilt University Medical Center · R37 · FY2024 · CA
Plasma-induced signatures as a measure disease heterogeneity and immunomodulation in T1D clinical trials
$523,418Martin John Hessner · Medical College Of Wisconsin · R01 · FY2020 · DK
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
$523,359Nicholas Chiorazzi · Feinstein Institute For Medical Research · R01 · FY2020 · CA
Mechanisms of T Cell Memory Quiescence
$523,322Surojit Sarkar · Seattle Children'S Hospital · R01 · FY2019 · AI
Mechanisms of T Cell Memory Quiescence
$523,322Surojit Sarkar · Seattle Children'S Hospital · R01 · FY2020 · AI
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
$523,308Nicholas Chiorazzi · Feinstein Institute For Medical Research · R01 · FY2024 · CA
Tumor matrix remodeling in anti-myeloma immunity and immunotherapy
$523,303Fotios Asimakopoulos · University Of California, San Diego · R01 · FY2020 · CA
MusIC: A multi-scale technology for integrating dynamic cellular function and molecular profiles
$523,272Navin Varadarajan · University Of Houston · R01 · FY2021 · GM
Extrinsic and intrinsic factors regulating commensal-specific T helper-17 cells
$523,250Bei Liu · Medical University Of South Carolina · U01 · FY2016 · AI
Tcf1 programs CD8 T cell responses to enhance viral and cancer immunity
$523,222Hai-Hui Xue · Hackensack University Medical Center · R01 · FY2021 · AI
GMP Biologics
$523,200Victor M Lemas · Johns Hopkins University · P30 · FY2017 · CA
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
$523,063Amnon Altman · La Jolla Institute For Immunology · R01 · FY2019 · CA
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
$523,063Michael Croft · La Jolla Institute For Immunology · R01 · FY2021 · CA
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
$523,063Amnon Altman · La Jolla Institute For Immunology · R01 · FY2020 · CA
CTCF in CD8 T cell homeostasis and anti-viral/tumor immunity
$523,039Hai-Hui Xue · Hackensack University Medical Center · R01 · FY2023 · AI
CTCF in CD8 T cell homeostasis and anti-viral/tumor immunity
$523,039Hai-Hui Xue · Hackensack University Medical Center · R01 · FY2025 · AI
CTCF in CD8 T cell homeostasis and anti-viral/tumor immunity
$523,039Hai-Hui Xue · Hackensack University Medical Center · R01 · FY2024 · AI
Localized immunotherapy using alum-binding therapeutics
$522,925Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2021 · EB